Investigation of serum tumor markers in the diagnosis of gastric cancer

Hepato-Gastroenterology

Volumn 58, Issue 105, 2011, Pages 239-245

  Fan, Biao ^a   Xiong, Bin ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

CA125; CA19 9; CA242; CEA; Gastric cancer; Tumor marker

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CA 242 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN BETA SUBUNIT; FERRITIN; GROWTH HORMONE; NEURONSPECIFIC ENOLASE; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOCHIP; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH CANCER; STOMACH CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79954997851     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Parkin DM, Bray FI, Devesa SS: Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37 Suppl 8:S4-66.
2. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108.
3. Yang L: Incidence and mortality of gastric cancer in China. World J Gastroenterol 2006; 12:17-20.
4. Sun XD, Mu R, Zhou YS, Dai XD, Zhang SW, Huangfu XM, Sun J, Li LD, Lu FZ, Qiao YL: Analysis of mortality rate of stomach cancer and its trend in twenty years in China. Zhonghua Zhong Liu Za Zhi 2004; 26:4-9.
5. Layke JC, Lopez PP: Gastric cancer: diagnosis and treatment options. Am Fam Physician 2004; 69:1133-1140.
6. Li S, Wang J, Lu Y, Fan D: Screening and early diagnosis of colorectal cancer in China: a 12 year retrospect (1994-2006). J Cancer Res Clin Oncol 2007; 133:679-686.
7. Sun Z, Fu X, Zhang L, Yang X, Liu F, Hu G: A protein chip system for parallel analysis of multi-tumor markers and its application in cancer detection. Anticancer Res 2004; 24:1159-1165. (Pubitemid 38624956)
8. Ando S, Kimura H, Iwai N, Shima M, Ando M, Kuriyama T: Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer. Anticancer Res 2001; 21:3085-3092. (Pubitemid 33051180)
9. Carpelan-Holmstrom M, Louhimo J, Stenman UH, Alfthan H, Haglund C: CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res 2002; 22:2311-2316.
10. Louhimo J, Kokkola A, Alfthan H, Stenman UH, Haglund C: Preoperative hCGbeta and CA 72-4 are prognostic factors in gastric cancer. Int J Cancer 2004; 111:929-933. (Pubitemid 39096242)
11. von EF, Davies H, Lomas L, Fiedler W, Junker K, Claussen U, Ernst G: Tissue-specific microdissection coupled with ProteinChip array technologies: applications in cancer research. Biotechniques 2000; 29:1066-1070.
12. Weinberger SR, Dalmasso EA, Fung ET: Current achievements using ProteinChip Array technology. Curr Opin Chem Biol 2002; 6:86-91. (Pubitemid 34122041)
13. Rubin RB, Merchant M: A rapid protein profiling system that speeds study of cancer and other diseases. Am Clin Lab 2000; 19:28-29.
14. Zhu H, Snyder M: Protein chip technology. Curr Opin Chem Biol 2003; 7:55-63. (Pubitemid 36126493)
15. Zuo Q, Li A, Miao J, Cai H, Lu H, Luo L: Diagnostic value of multi-tumor markers protein biochip detective system for diagestive tract cancer. J Clin Oncol 2004; 6:337-339. (In Chinese with English abstract)
16. Lang Z, Wang H, Wu A, Fu S: Clinical value of 12 tumor markers protein biochip in detection of digestive system neoplasm. China Trop Med 2005; 3:407-409. (In Chinese with English abstract)
17. Dong X, Zheng Z, Chen J, Chi J, Fu Y, Wang W: Screening of gastric cancer relation tumor markers from proteinchip multi-tumor markers. Chin J Lab Diagn 1 2005; 88-90. (In Chinese with English abstract)
18. Gu Y, Wang X, Jin C, Chen Y, Wu Z, Huang Y: The characteristic of tumor markers in sera of patients with gastric carcinoma and clinic significance. Cancer Research and Clinic 2005; 5:329-331. (In Chinese with English abstract)
19. Zhang X, Zhou J, Wang C, Zhuang Q: Clinical application of protein biochip system for detecting multi-marker of tumor. Modern Oncology 2005; 6:782-783. (In Chinese with English abstract)
20. Jiang Z, Zhou W, Lin W, Huang Q: Application of Multi-tumor Markers Protein Chip Diagnose System in the Diagnosing of Intestinal Neoplasms. J Mod Lab Med 1 2005; 17-19. (In Chinese with English abstract)
21. Yu D: Application of multi-tumor markers protein chip assistance diagnostic system for detection of various tumor. China Trop Med 2005; 3:414-416. (In Chinese with English abstract)
22. Ishigami S, Natsugoe S, Hokita S, Che X, Tokuda K, Nakajo A, Iwashige H, Tokushige M, Watanabe T, Takao S, Aikou T: Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer. J Clin Gastroenterol 2001; 32:41-44. (Pubitemid 32038110)
23. Lai IR, Lee WJ, Huang MT, Lin HH: Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Hepatogastroenterology 2002; 49:1157-1160.
24. Gaspar MJ, Arribas I, Coca MC, ez-Alonso M: Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma. Tumour Biol 2001; 22:318-322.
25. Ucar E, Semerci E, Ustun H, Yetim T, Huzmeli C, Gullu M: Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer. Adv Ther 2008; 25:1075-1084.
26. Louhimo J, Finne P, Alfthan H, Stenman UH, Haglund C: Combination of HCGbeta, CA 19-9 and CEA with logistic regression improves accuracy in gastrointestinal malignancies. Anticancer Res 2002; 22:1759-1764.
27. Molnar IG, Vandevoorde JP, Gitnick GL: CEA levels in fluids bathing gastrointestinal tumors. Gastroenterology 1976; 70:513-515.
28. Ychou M, Duffour J, Kramar A, Gourgou S, Grenier J: Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Dis Markers 2000; 16:105-110. (Pubitemid 32591564)
29. Marrelli D, Pinto E, De SA, Farnetani M, Garosi L, Roviello F: Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer. Am J Surg 2001; 181:16-19. (Pubitemid 32209115)
30. Schneider J, Schulze G: Comparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancer. Anticancer Res 2003; 23:5089-5093. (Pubitemid 38182129)
31. Guadagni F, Roselli M, Amato T, Cosimelli M, Perri P, Casale V, Carlini M, Santoro E, Cavaliere R, Greiner JW: CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma. Cancer Res 1992; 52:1222-1227.
32. Heptner G, Domschke S, Domschke W: Comparison of CA 72-4 with CA 19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies. Scand J Gastroenterol 1989; 24:745-750. (Pubitemid 19211668)
33. Marrelli D, Roviello F, De SA, Farnetani M, Garosi L, Messano A, Pinto E: Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology 1999; 57:55-62.